
CAS 120005-55-2
:CAY10621
- YGBSGZPIDCXNEH-QFIPXVFZSA-N
- CAY10621
- SKI 5C
- 2,2-Dimethyl-4S-(1-oxo-2-hexadecyn-1-yl)-1,1-dimethylethyl ester-3-oxazolidinecarboxylic acid
- SPHK1 Inhibitor 5C
SKI 5C
CAS :SKI 5C is a small-molecule inhibitor, which is synthetically derived with a unique mechanism that targets specific signaling pathways involved in cancer cell proliferation. The source of SKI 5C lies in its synthetic chemistry, designed to interact precisely with cellular components that regulate growth signals within cancerous cells. Its mode of action includes the inhibition of key enzymes and receptors involved in these pathways, effectively disrupting the processes that lead to uncontrolled cell division.
In research and clinical applications, SKI 5C is primarily used to study and potentially treat malignancies characterized by aberrant signaling activities. By selectively targeting cancer cells while sparing normal cells, SKI 5C provides a valuable model for understanding the molecular dynamics of cancer growth and resistance. Its precise intervention in cellular signaling cascades makes it an important tool for experimental therapeutics and biomarker discovery, offering insights into new avenues for targeted oncological therapies. Through its application, SKI 5C contributes to the broader research goals of improving the specificity and efficacy of cancer treatments.Formule :C26H45NO4Degré de pureté :Min. 95%Masse moléculaire :435.64 g/molSKI 5C
CAS :SKI 5C is a selective inhibitor of Sphingosine Kinase 1.Formule :C26H45NO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :435.64


